MaxCyte falls after $151.8M deal to buy Akron Bio for cash and stock
at seekingalpha.com (Tue, 10-Nov 12:40 PM)
MaxCyte Reports Strong Third-Quarter Revenue Growth and Narrower Loss
at www.tipranks.com (Tue, 10-Nov 8:46 AM)
MaxCyte beats Q3 EPS and revenue estimates, issues FY revenue guidance above consensus
at seekingalpha.com (Tue, 10-Nov 6:06 AM)
MXCT jumps after preliminary Q3 revenue points to a guidance raise to about $34 million
Market Chameleon (Wed, 14-Oct 9:54 AM)
Market Chameleon (Thu, 13-Aug 10:38 AM)
